Sodium Zirconium Cyclosilicate
Brand name: Lokelma
Rank #224 of 500 drugs by total cost
$60.2M
Total Cost
77,902
Total Claims
$60.2M
Total Cost
2,986
Prescribers
$773
Cost per Claim
12,461
Beneficiaries
100,416
30-Day Fills
$20K
Avg Cost/Provider
26
Avg Claims/Provider
About Sodium Zirconium Cyclosilicate
Sodium Zirconium Cyclosilicate (sold as Lokelma) was prescribed 77,902 times by 2,986 Medicare Part D providers in 2023, costing the program $60.2M. At $773 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 221 | Ferric Citrate (Auryxia) | $60.7M | 32,798 |
| 222 | Dextromethorphan Hbr/Quinidine (Nuedexta) | $60.7M | 60,863 |
| 223 | Interferon Beta-1a/Albumin (Rebif) | $60.7M | 5,917 |
| 224 | Sodium Zirconium Cyclosilicate (Lokelma) | $60.2M | 77,902 |
| 225 | Golimumab (Simponi Aria) | $59.9M | 8,718 |
| 226 | Olanzapine (Olanzapine) | $59.4M | 1,444,781 |
| 227 | Metoprolol Tartrate (Metoprolol Tartrate) | $59.4M | 6,859,124 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology